HMS announces the acquisition of IntegriGuard

HMS today announced that it has acquired the business of IntegriGuard LLC, an ISO-certified and URAC-accredited organization devoted to the prevention and detection of fraud, waste, and abuse in the healthcare system. The company is based in Omaha, Nebraska and will operate as a wholly-owned subsidiary of HMS Holdings Corp.

IntegriGuard offers a suite of program integrity and payment accuracy solutions designed to detect fraud and improper payments. The company's services include audit, compliance and education, data and analysis, eligibility verification, medical review, and investigation services.

In addition to being designated by the Centers for Medicare and Medicaid Services (CMS) as one of 12 Program Safeguard Contractors and one of eight MEDIC contractors, IntegriGuard is one of eight Qualified Independent Contractors for CMS.

"IntegriGuard significantly enhances HMS's ability to serve the Medicare program, and immediately doubles our presence in the Federal market," said Bill Lucia, CEO of HMS. "As a combined company, we are in an excellent position to respond to CMS's increased focus on fraud, waste, and abuse identification, and extend IntegriGuard's capabilities to other healthcare markets."

The purchase price was $5.25 million paid in cash. IntegriGuard projects revenues of approximately $12 million for the fiscal year ending March 31, 2010. HMS does not expect this transaction to have a material impact on its 2009 financial results.

Source:

HMS Holdings Corp.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exploring the potential of personalized precision medicine for healthcare industry